The UPC Case UPC_CFI_607/2025 was filed on 08 Jul, 2025 by the plaintiff Moderna against the defendant Arbutus Biopharma.
Case Number:
UPC_CFI_607/2025
Patent Number:
Filing Date:
08 Jul, 2025
Proceeding Type:
Counter Claim For Revocation
Case Phase:
Written Phase
Plaintiffs:
Plaintiff Representatives:
Defendants:
Defendant Representatives:
Judges:
Decision pending - set alert to receive updates
The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.
Date | Title | Link |
---|---|---|
Sep 17, 2025 | Panel Appointment | - |
Sep 11, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 11, 2025 | Acknowledgement Of Lodging | - |
Sep 10, 2025 | Reply To Sod + Defence To Cc + App To Amend | - |
Sep 10, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 10, 2025 | Exhibit A118 Moderna It Webpage | - |
Sep 10, 2025 | Exhibit A118 Moderna Italy Webpage | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain, Moderna Switzerland And Moderna Netherlan | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla | - |
Sep 10, 2025 | Exhibit A116 Moderna Es Supply Invoicing Eu States | - |
Sep 10, 2025 | Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version) | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant Cla Sec | - |
Sep 10, 2025 | Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O | - |
Sep 10, 2025 | Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery | - |
Sep 10, 2025 | Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis | - |
Sep 10, 2025 | Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid | - |
Sep 10, 2025 | Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information | - |
Sep 10, 2025 | Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery | - |
Sep 10, 2025 | Exhibit A108 US61/231,579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A108 US61 231.579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A107 US61/159,788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A107 US61 159.788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A106 US61/222,464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A106 US61 222.464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A105 US61/222/469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A105 US61 222.469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A104 US61/258,848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A104 US61 258.848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A103 US61/251,999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A103 US61 251.999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A102 US61/242,761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A102 US61 242.761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A101 US61/234,045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A101 US61 234.045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A100 US61/175,777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A100 US61 175.777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A099 Register Extract Of Fbd T 66 | - |
Sep 10, 2025 | Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes) | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery: Improved Endosomal Escape And Sustained Pharm | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar | - |
Sep 10, 2025 | Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration | - |
Sep 10, 2025 | Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids | - |
Sep 10, 2025 | Exhibit A092 EP767Claim Requests (Tracked Changes Version) | - |
Sep 10, 2025 | Exhibit A091 EP767Claim Requests (Clean Version) | - |
Sep 10, 2025 | Acknowledgement Of Lodging | - |
Jul 29, 2025 | Notification Of Service | - |
Jul 29, 2025 | Acknowledgement Of Access To Case | - |
Jul 25, 2025 | Epo Communication Check Outcome | - |
Jul 23, 2025 | Epo Communication Check Outcome | - |
Jul 22, 2025 | Document From Epo | - |
Jul 21, 2025 | Document From Epo | - |
Jul 17, 2025 | Panel Appointment | - |
Jul 17, 2025 | Formal Checks Notification Of Positive Outcome | - |
Jul 17, 2025 | Exhibit Fbd T 9 | - |
Jul 17, 2025 | Exhibit Fbd T 8 | - |
Jul 17, 2025 | Exhibit Fbd T 70 | - |
Jul 17, 2025 | Exhibit Fbd T 7 | - |
Jul 17, 2025 | Exhibit Fbd T 69 | - |
Jul 17, 2025 | Exhibit Fbd T 68 | - |
Jul 17, 2025 | Exhibit Fbd T 67 | - |
Jul 17, 2025 | Exhibit Fbd T 66 | - |
Jul 17, 2025 | Exhibit Fbd T 65 | - |
Jul 17, 2025 | Exhibit Fbd T 64 | - |
Jul 17, 2025 | Exhibit Fbd T 63 | - |
Jul 17, 2025 | Exhibit Fbd T 62 | - |
Jul 17, 2025 | Exhibit Fbd T 61 | - |
Jul 17, 2025 | Exhibit Fbd T 60 | - |
Jul 17, 2025 | Exhibit Fbd T 6 | - |
Jul 17, 2025 | Exhibit Fbd T 59 | - |
Jul 17, 2025 | Exhibit Fbd T 58 | - |
Jul 17, 2025 | Exhibit Fbd T 57 | - |
Jul 17, 2025 | Exhibit Fbd T 56 | - |
Jul 17, 2025 | Exhibit Fbd T 55 | - |
Jul 17, 2025 | Exhibit Fbd T 54 | - |
Jul 17, 2025 | Exhibit Fbd T 53 | - |
Jul 17, 2025 | Exhibit Fbd T 52 | - |
Jul 17, 2025 | Exhibit Fbd T 51 | - |
Jul 17, 2025 | Exhibit Fbd T 50 | - |
Jul 17, 2025 | Exhibit Fbd T 5 | - |
Jul 17, 2025 | Exhibit Fbd T 49 | - |
Jul 17, 2025 | Exhibit Fbd T 48 | - |
Jul 17, 2025 | Exhibit Fbd T 47 | - |
Jul 17, 2025 | Exhibit Fbd T 46 | - |
Jul 17, 2025 | Exhibit Fbd T 45 | - |
Jul 17, 2025 | Exhibit Fbd T 44 | - |
Jul 17, 2025 | Exhibit Fbd T 43 | - |
Jul 17, 2025 | Exhibit Fbd T 42 | - |
Jul 17, 2025 | Exhibit Fbd T 41 | - |
Jul 17, 2025 | Exhibit Fbd T 40 | - |
Jul 17, 2025 | Exhibit Fbd T 4 | - |
Jul 17, 2025 | Exhibit Fbd T 39 | - |
Jul 17, 2025 | Exhibit Fbd T 38 | - |
Jul 17, 2025 | Exhibit Fbd T 37 | - |
Jul 17, 2025 | Exhibit Fbd T 36 | - |
Jul 17, 2025 | Exhibit Fbd T 35 | - |
Jul 17, 2025 | Exhibit Fbd T 34 | - |
Jul 17, 2025 | Exhibit Fbd T 33 | - |
Jul 17, 2025 | Exhibit Fbd T 32 | - |
Jul 17, 2025 | Exhibit Fbd T 31 | - |
Jul 17, 2025 | Exhibit Fbd T 30 | - |
Jul 17, 2025 | Exhibit Fbd T 3 | - |
Jul 17, 2025 | Exhibit Fbd T 29 | - |
Jul 17, 2025 | Exhibit Fbd T 28 | - |
Jul 17, 2025 | Exhibit Fbd T 27 | - |
Jul 17, 2025 | Exhibit Fbd T 26 | - |
Jul 17, 2025 | Exhibit Fbd T 25 | - |
Jul 17, 2025 | Exhibit Fbd T 24 | - |
Jul 17, 2025 | Exhibit Fbd T 23 | - |
Jul 17, 2025 | Exhibit Fbd T 22 | - |
Jul 17, 2025 | Exhibit Fbd T 21 | - |
Jul 17, 2025 | Exhibit Fbd T 20 | - |
Jul 17, 2025 | Exhibit Fbd T 2 | - |
Jul 17, 2025 | Exhibit Fbd T 19 | - |
Jul 17, 2025 | Exhibit Fbd T 18 | - |
Jul 17, 2025 | Exhibit Fbd T 17 | - |
Jul 17, 2025 | Exhibit Fbd T 16 | - |
Jul 17, 2025 | Exhibit Fbd T 15 | - |
Jul 17, 2025 | Exhibit Fbd T 14 | - |
Jul 17, 2025 | Exhibit Fbd T 13 | - |
Jul 17, 2025 | Exhibit Fbd T 12 | - |
Jul 17, 2025 | Exhibit Fbd T 11 | - |
Jul 17, 2025 | Exhibit Fbd T 10 | - |
Jul 17, 2025 | Exhibit Fbd T 1 | - |
Jul 17, 2025 | Epo Request For Case Pending | - |
Jul 17, 2025 | Acknowledgement Of Lodging | - |
Jul 17, 2025 | 25 07 17 Moderna Vs Genevant Arbutus EP767 Formal Response To Request For Amendments Cc 318331 2025 | - |
Jul 17, 2025 | 07 08 Upc2 EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
Jul 10, 2025 | Formal Checks Request For Correction | - |
Jul 8, 2025 | Exhibit Fbd T 9 | - |
Jul 8, 2025 | Exhibit Fbd T 8 | - |
Jul 8, 2025 | Exhibit Fbd T 70 | - |
Jul 8, 2025 | Exhibit Fbd T 7 | - |
Jul 8, 2025 | Exhibit Fbd T 69 | - |
Jul 8, 2025 | Exhibit Fbd T 68 | - |
Jul 8, 2025 | Exhibit Fbd T 67 | - |
Jul 8, 2025 | Exhibit Fbd T 66 | - |
Jul 8, 2025 | Exhibit Fbd T 65 | - |
Jul 8, 2025 | Exhibit Fbd T 64 | - |
Jul 8, 2025 | Exhibit Fbd T 63 | - |
Jul 8, 2025 | Exhibit Fbd T 62 | - |
Jul 8, 2025 | Exhibit Fbd T 61 | - |
Jul 8, 2025 | Exhibit Fbd T 60 | - |
Jul 8, 2025 | Exhibit Fbd T 6 | - |
Jul 8, 2025 | Exhibit Fbd T 59 | - |
Jul 8, 2025 | Exhibit Fbd T 58 | - |
Jul 8, 2025 | Exhibit Fbd T 57 | - |
Jul 8, 2025 | Exhibit Fbd T 56 | - |
Jul 8, 2025 | Exhibit Fbd T 55 | - |
Jul 8, 2025 | Exhibit Fbd T 54 | - |
Jul 8, 2025 | Exhibit Fbd T 53 | - |
Jul 8, 2025 | Exhibit Fbd T 52 | - |
Jul 8, 2025 | Exhibit Fbd T 51 | - |
Jul 8, 2025 | Exhibit Fbd T 50 | - |
Jul 8, 2025 | Exhibit Fbd T 5 | - |
Jul 8, 2025 | Exhibit Fbd T 49 | - |
Jul 8, 2025 | Exhibit Fbd T 48 | - |
Jul 8, 2025 | Exhibit Fbd T 47 | - |
Jul 8, 2025 | Exhibit Fbd T 46 | - |
Jul 8, 2025 | Exhibit Fbd T 45 | - |
Jul 8, 2025 | Exhibit Fbd T 44 | - |
Jul 8, 2025 | Exhibit Fbd T 43 | - |
Jul 8, 2025 | Exhibit Fbd T 42 | - |
Jul 8, 2025 | Exhibit Fbd T 41 | - |
Jul 8, 2025 | Exhibit Fbd T 40 | - |
Jul 8, 2025 | Exhibit Fbd T 4 | - |
Jul 8, 2025 | Exhibit Fbd T 39 | - |
Jul 8, 2025 | Exhibit Fbd T 38 | - |
Jul 8, 2025 | Exhibit Fbd T 37 | - |
Jul 8, 2025 | Exhibit Fbd T 36 | - |
Jul 8, 2025 | Exhibit Fbd T 35 | - |
Jul 8, 2025 | Exhibit Fbd T 34 | - |
Jul 8, 2025 | Exhibit Fbd T 33 | - |
Jul 8, 2025 | Exhibit Fbd T 32 | - |
Jul 8, 2025 | Exhibit Fbd T 31 | - |
Jul 8, 2025 | Exhibit Fbd T 30 | - |
Jul 8, 2025 | Exhibit Fbd T 3 | - |
Jul 8, 2025 | Exhibit Fbd T 29 | - |
Jul 8, 2025 | Exhibit Fbd T 28 | - |
Jul 8, 2025 | Exhibit Fbd T 27 | - |
Jul 8, 2025 | Exhibit Fbd T 26 | - |
Jul 8, 2025 | Exhibit Fbd T 25 | - |
Jul 8, 2025 | Exhibit Fbd T 24 | - |
Jul 8, 2025 | Exhibit Fbd T 23 | - |
Jul 8, 2025 | Exhibit Fbd T 22 | - |
Jul 8, 2025 | Exhibit Fbd T 21 | - |
Jul 8, 2025 | Exhibit Fbd T 20 | - |
Jul 8, 2025 | Exhibit Fbd T 2 | - |
Jul 8, 2025 | Exhibit Fbd T 19 | - |
Jul 8, 2025 | Exhibit Fbd T 18 | - |
Jul 8, 2025 | Exhibit Fbd T 17 | - |
Jul 8, 2025 | Exhibit Fbd T 16 | - |
Jul 8, 2025 | Exhibit Fbd T 15 | - |
Jul 8, 2025 | Exhibit Fbd T 14 | - |
Jul 8, 2025 | Exhibit Fbd T 13 | - |
Jul 8, 2025 | Exhibit Fbd T 12 | - |
Jul 8, 2025 | Exhibit Fbd T 11 | - |
Jul 8, 2025 | Exhibit Fbd T 10 | - |
Jul 8, 2025 | Exhibit Fbd T 1 | - |
Jul 8, 2025 | EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
Sep 17, 2025 | Panel Appointment | - |
Sep 11, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 11, 2025 | Acknowledgement Of Lodging | - |
Sep 10, 2025 | Reply To Sod + Defence To Cc + App To Amend | - |
Sep 10, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 10, 2025 | Exhibit A118 Moderna It Webpage | - |
Sep 10, 2025 | Exhibit A118 Moderna Italy Webpage | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain, Moderna Switzerland And Moderna Netherlan | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla | - |
Sep 10, 2025 | Exhibit A116 Moderna Es Supply Invoicing Eu States | - |
Sep 10, 2025 | Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version) | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant Cla Sec | - |
Sep 10, 2025 | Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O | - |
Sep 10, 2025 | Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery | - |
Sep 10, 2025 | Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis | - |
Sep 10, 2025 | Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid | - |
Sep 10, 2025 | Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information | - |
Sep 10, 2025 | Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery | - |
Sep 10, 2025 | Exhibit A108 US61/231,579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A108 US61 231.579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A107 US61/159,788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A107 US61 159.788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A106 US61/222,464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A106 US61 222.464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A105 US61/222/469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A105 US61 222.469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A104 US61/258,848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A104 US61 258.848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A103 US61/251,999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A103 US61 251.999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A102 US61/242,761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A102 US61 242.761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A101 US61/234,045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A101 US61 234.045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A100 US61/175,777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A100 US61 175.777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A099 Register Extract Of Fbd T 66 | - |
Sep 10, 2025 | Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes) | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery: Improved Endosomal Escape And Sustained Pharm | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar | - |
Sep 10, 2025 | Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration | - |
Sep 10, 2025 | Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids | - |
Sep 10, 2025 | Exhibit A092 EP767Claim Requests (Tracked Changes Version) | - |
Sep 10, 2025 | Exhibit A091 EP767Claim Requests (Clean Version) | - |
Sep 10, 2025 | Acknowledgement Of Lodging | - |
Jul 29, 2025 | Notification Of Service | - |
Jul 29, 2025 | Acknowledgement Of Access To Case | - |
Jul 25, 2025 | Epo Communication Check Outcome | - |
Jul 23, 2025 | Epo Communication Check Outcome | - |
Jul 22, 2025 | Document From Epo | - |
Jul 21, 2025 | Document From Epo | - |
Jul 17, 2025 | Panel Appointment | - |
Jul 17, 2025 | Formal Checks Notification Of Positive Outcome | - |
Jul 17, 2025 | Exhibit Fbd T 9 | - |
Jul 17, 2025 | Exhibit Fbd T 8 | - |
Jul 17, 2025 | Exhibit Fbd T 70 | - |
Jul 17, 2025 | Exhibit Fbd T 7 | - |
Jul 17, 2025 | Exhibit Fbd T 69 | - |
Jul 17, 2025 | Exhibit Fbd T 68 | - |
Jul 17, 2025 | Exhibit Fbd T 67 | - |
Jul 17, 2025 | Exhibit Fbd T 66 | - |
Jul 17, 2025 | Exhibit Fbd T 65 | - |
Jul 17, 2025 | Exhibit Fbd T 64 | - |
Jul 17, 2025 | Exhibit Fbd T 63 | - |
Jul 17, 2025 | Exhibit Fbd T 62 | - |
Jul 17, 2025 | Exhibit Fbd T 61 | - |
Jul 17, 2025 | Exhibit Fbd T 60 | - |
Jul 17, 2025 | Exhibit Fbd T 6 | - |
Jul 17, 2025 | Exhibit Fbd T 59 | - |
Jul 17, 2025 | Exhibit Fbd T 58 | - |
Jul 17, 2025 | Exhibit Fbd T 57 | - |
Jul 17, 2025 | Exhibit Fbd T 56 | - |
Jul 17, 2025 | Exhibit Fbd T 55 | - |
Jul 17, 2025 | Exhibit Fbd T 54 | - |
Jul 17, 2025 | Exhibit Fbd T 53 | - |
Jul 17, 2025 | Exhibit Fbd T 52 | - |
Jul 17, 2025 | Exhibit Fbd T 51 | - |
Jul 17, 2025 | Exhibit Fbd T 50 | - |
Jul 17, 2025 | Exhibit Fbd T 5 | - |
Jul 17, 2025 | Exhibit Fbd T 49 | - |
Jul 17, 2025 | Exhibit Fbd T 48 | - |
Jul 17, 2025 | Exhibit Fbd T 47 | - |
Jul 17, 2025 | Exhibit Fbd T 46 | - |
Jul 17, 2025 | Exhibit Fbd T 45 | - |
Jul 17, 2025 | Exhibit Fbd T 44 | - |
Jul 17, 2025 | Exhibit Fbd T 43 | - |
Jul 17, 2025 | Exhibit Fbd T 42 | - |
Jul 17, 2025 | Exhibit Fbd T 41 | - |
Jul 17, 2025 | Exhibit Fbd T 40 | - |
Jul 17, 2025 | Exhibit Fbd T 4 | - |
Jul 17, 2025 | Exhibit Fbd T 39 | - |
Jul 17, 2025 | Exhibit Fbd T 38 | - |
Jul 17, 2025 | Exhibit Fbd T 37 | - |
Jul 17, 2025 | Exhibit Fbd T 36 | - |
Jul 17, 2025 | Exhibit Fbd T 35 | - |
Jul 17, 2025 | Exhibit Fbd T 34 | - |
Jul 17, 2025 | Exhibit Fbd T 33 | - |
Jul 17, 2025 | Exhibit Fbd T 32 | - |
Jul 17, 2025 | Exhibit Fbd T 31 | - |
Jul 17, 2025 | Exhibit Fbd T 30 | - |
Jul 17, 2025 | Exhibit Fbd T 3 | - |
Jul 17, 2025 | Exhibit Fbd T 29 | - |
Jul 17, 2025 | Exhibit Fbd T 28 | - |
Jul 17, 2025 | Exhibit Fbd T 27 | - |
Jul 17, 2025 | Exhibit Fbd T 26 | - |
Jul 17, 2025 | Exhibit Fbd T 25 | - |
Jul 17, 2025 | Exhibit Fbd T 24 | - |
Jul 17, 2025 | Exhibit Fbd T 23 | - |
Jul 17, 2025 | Exhibit Fbd T 22 | - |
Jul 17, 2025 | Exhibit Fbd T 21 | - |
Jul 17, 2025 | Exhibit Fbd T 20 | - |
Jul 17, 2025 | Exhibit Fbd T 2 | - |
Jul 17, 2025 | Exhibit Fbd T 19 | - |
Jul 17, 2025 | Exhibit Fbd T 18 | - |
Jul 17, 2025 | Exhibit Fbd T 17 | - |
Jul 17, 2025 | Exhibit Fbd T 16 | - |
Jul 17, 2025 | Exhibit Fbd T 15 | - |
Jul 17, 2025 | Exhibit Fbd T 14 | - |
Jul 17, 2025 | Exhibit Fbd T 13 | - |
Jul 17, 2025 | Exhibit Fbd T 12 | - |
Jul 17, 2025 | Exhibit Fbd T 11 | - |
Jul 17, 2025 | Exhibit Fbd T 10 | - |
Jul 17, 2025 | Exhibit Fbd T 1 | - |
Jul 17, 2025 | Epo Request For Case Pending | - |
Jul 17, 2025 | Acknowledgement Of Lodging | - |
Jul 17, 2025 | 25 07 17 Moderna Vs Genevant Arbutus EP767 Formal Response To Request For Amendments Cc 318331 2025 | - |
Jul 17, 2025 | 07 08 Upc2 EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
Jul 10, 2025 | Formal Checks Request For Correction | - |
Jul 8, 2025 | Exhibit Fbd T 9 | - |
Jul 8, 2025 | Exhibit Fbd T 8 | - |
Jul 8, 2025 | Exhibit Fbd T 70 | - |
Jul 8, 2025 | Exhibit Fbd T 7 | - |
Jul 8, 2025 | Exhibit Fbd T 69 | - |
Jul 8, 2025 | Exhibit Fbd T 68 | - |
Jul 8, 2025 | Exhibit Fbd T 67 | - |
Jul 8, 2025 | Exhibit Fbd T 66 | - |
Jul 8, 2025 | Exhibit Fbd T 65 | - |
Jul 8, 2025 | Exhibit Fbd T 64 | - |
Jul 8, 2025 | Exhibit Fbd T 63 | - |
Jul 8, 2025 | Exhibit Fbd T 62 | - |
Jul 8, 2025 | Exhibit Fbd T 61 | - |
Jul 8, 2025 | Exhibit Fbd T 60 | - |
Jul 8, 2025 | Exhibit Fbd T 6 | - |
Jul 8, 2025 | Exhibit Fbd T 59 | - |
Jul 8, 2025 | Exhibit Fbd T 58 | - |
Jul 8, 2025 | Exhibit Fbd T 57 | - |
Jul 8, 2025 | Exhibit Fbd T 56 | - |
Jul 8, 2025 | Exhibit Fbd T 55 | - |
Jul 8, 2025 | Exhibit Fbd T 54 | - |
Jul 8, 2025 | Exhibit Fbd T 53 | - |
Jul 8, 2025 | Exhibit Fbd T 52 | - |
Jul 8, 2025 | Exhibit Fbd T 51 | - |
Jul 8, 2025 | Exhibit Fbd T 50 | - |
Jul 8, 2025 | Exhibit Fbd T 5 | - |
Jul 8, 2025 | Exhibit Fbd T 49 | - |
Jul 8, 2025 | Exhibit Fbd T 48 | - |
Jul 8, 2025 | Exhibit Fbd T 47 | - |
Jul 8, 2025 | Exhibit Fbd T 46 | - |
Jul 8, 2025 | Exhibit Fbd T 45 | - |
Jul 8, 2025 | Exhibit Fbd T 44 | - |
Jul 8, 2025 | Exhibit Fbd T 43 | - |
Jul 8, 2025 | Exhibit Fbd T 42 | - |
Jul 8, 2025 | Exhibit Fbd T 41 | - |
Jul 8, 2025 | Exhibit Fbd T 40 | - |
Jul 8, 2025 | Exhibit Fbd T 4 | - |
Jul 8, 2025 | Exhibit Fbd T 39 | - |
Jul 8, 2025 | Exhibit Fbd T 38 | - |
Jul 8, 2025 | Exhibit Fbd T 37 | - |
Jul 8, 2025 | Exhibit Fbd T 36 | - |
Jul 8, 2025 | Exhibit Fbd T 35 | - |
Jul 8, 2025 | Exhibit Fbd T 34 | - |
Jul 8, 2025 | Exhibit Fbd T 33 | - |
Jul 8, 2025 | Exhibit Fbd T 32 | - |
Jul 8, 2025 | Exhibit Fbd T 31 | - |
Jul 8, 2025 | Exhibit Fbd T 30 | - |
Jul 8, 2025 | Exhibit Fbd T 3 | - |
Jul 8, 2025 | Exhibit Fbd T 29 | - |
Jul 8, 2025 | Exhibit Fbd T 28 | - |
Jul 8, 2025 | Exhibit Fbd T 27 | - |
Jul 8, 2025 | Exhibit Fbd T 26 | - |
Jul 8, 2025 | Exhibit Fbd T 25 | - |
Jul 8, 2025 | Exhibit Fbd T 24 | - |
Jul 8, 2025 | Exhibit Fbd T 23 | - |
Jul 8, 2025 | Exhibit Fbd T 22 | - |
Jul 8, 2025 | Exhibit Fbd T 21 | - |
Jul 8, 2025 | Exhibit Fbd T 20 | - |
Jul 8, 2025 | Exhibit Fbd T 2 | - |
Jul 8, 2025 | Exhibit Fbd T 19 | - |
Jul 8, 2025 | Exhibit Fbd T 18 | - |
Jul 8, 2025 | Exhibit Fbd T 17 | - |
Jul 8, 2025 | Exhibit Fbd T 16 | - |
Jul 8, 2025 | Exhibit Fbd T 15 | - |
Jul 8, 2025 | Exhibit Fbd T 14 | - |
Jul 8, 2025 | Exhibit Fbd T 13 | - |
Jul 8, 2025 | Exhibit Fbd T 12 | - |
Jul 8, 2025 | Exhibit Fbd T 11 | - |
Jul 8, 2025 | Exhibit Fbd T 10 | - |
Jul 8, 2025 | Exhibit Fbd T 1 | - |
Jul 8, 2025 | EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
Sep 17, 2025 | Panel Appointment | - |
Sep 11, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 11, 2025 | Acknowledgement Of Lodging | - |
Sep 10, 2025 | Reply To Sod + Defence To Cc + App To Amend | - |
Sep 10, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 10, 2025 | Exhibit A118 Moderna It Webpage | - |
Sep 10, 2025 | Exhibit A118 Moderna Italy Webpage | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain, Moderna Switzerland And Moderna Netherlan | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla | - |
Sep 10, 2025 | Exhibit A116 Moderna Es Supply Invoicing Eu States | - |
Sep 10, 2025 | Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version) | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant Cla Sec | - |
Sep 10, 2025 | Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O | - |
Sep 10, 2025 | Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery | - |
Sep 10, 2025 | Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis | - |
Sep 10, 2025 | Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid | - |
Sep 10, 2025 | Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information | - |
Sep 10, 2025 | Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery | - |
Sep 10, 2025 | Exhibit A108 US61/231,579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A108 US61 231.579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A107 US61/159,788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A107 US61 159.788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A106 US61/222,464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A106 US61 222.464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A105 US61/222/469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A105 US61 222.469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A104 US61/258,848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A104 US61 258.848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A103 US61/251,999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A103 US61 251.999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A102 US61/242,761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A102 US61 242.761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A101 US61/234,045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A101 US61 234.045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A100 US61/175,777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A100 US61 175.777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A099 Register Extract Of Fbd T 66 | - |
Sep 10, 2025 | Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes) | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery: Improved Endosomal Escape And Sustained Pharm | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar | - |
Sep 10, 2025 | Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration | - |
Sep 10, 2025 | Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids | - |
Sep 10, 2025 | Exhibit A092 EP767Claim Requests (Tracked Changes Version) | - |
Sep 10, 2025 | Exhibit A091 EP767Claim Requests (Clean Version) | - |
Sep 10, 2025 | Acknowledgement Of Lodging | - |
Jul 29, 2025 | Notification Of Service | - |
Jul 29, 2025 | Acknowledgement Of Access To Case | - |
Jul 25, 2025 | Epo Communication Check Outcome | - |
Jul 23, 2025 | Epo Communication Check Outcome | - |
Jul 22, 2025 | Document From Epo | - |
Jul 21, 2025 | Document From Epo | - |
Jul 17, 2025 | Panel Appointment | - |
Jul 17, 2025 | Formal Checks Notification Of Positive Outcome | - |
Jul 17, 2025 | Exhibit Fbd T 9 | - |
Jul 17, 2025 | Exhibit Fbd T 8 | - |
Jul 17, 2025 | Exhibit Fbd T 70 | - |
Jul 17, 2025 | Exhibit Fbd T 7 | - |
Jul 17, 2025 | Exhibit Fbd T 69 | - |
Jul 17, 2025 | Exhibit Fbd T 68 | - |
Jul 17, 2025 | Exhibit Fbd T 67 | - |
Jul 17, 2025 | Exhibit Fbd T 66 | - |
Jul 17, 2025 | Exhibit Fbd T 65 | - |
Jul 17, 2025 | Exhibit Fbd T 64 | - |
Jul 17, 2025 | Exhibit Fbd T 63 | - |
Jul 17, 2025 | Exhibit Fbd T 62 | - |
Jul 17, 2025 | Exhibit Fbd T 61 | - |
Jul 17, 2025 | Exhibit Fbd T 60 | - |
Jul 17, 2025 | Exhibit Fbd T 6 | - |
Jul 17, 2025 | Exhibit Fbd T 59 | - |
Jul 17, 2025 | Exhibit Fbd T 58 | - |
Jul 17, 2025 | Exhibit Fbd T 57 | - |
Jul 17, 2025 | Exhibit Fbd T 56 | - |
Jul 17, 2025 | Exhibit Fbd T 55 | - |
Jul 17, 2025 | Exhibit Fbd T 54 | - |
Jul 17, 2025 | Exhibit Fbd T 53 | - |
Jul 17, 2025 | Exhibit Fbd T 52 | - |
Jul 17, 2025 | Exhibit Fbd T 51 | - |
Jul 17, 2025 | Exhibit Fbd T 50 | - |
Jul 17, 2025 | Exhibit Fbd T 5 | - |
Jul 17, 2025 | Exhibit Fbd T 49 | - |
Jul 17, 2025 | Exhibit Fbd T 48 | - |
Jul 17, 2025 | Exhibit Fbd T 47 | - |
Jul 17, 2025 | Exhibit Fbd T 46 | - |
Jul 17, 2025 | Exhibit Fbd T 45 | - |
Jul 17, 2025 | Exhibit Fbd T 44 | - |
Jul 17, 2025 | Exhibit Fbd T 43 | - |
Jul 17, 2025 | Exhibit Fbd T 42 | - |
Jul 17, 2025 | Exhibit Fbd T 41 | - |
Jul 17, 2025 | Exhibit Fbd T 40 | - |
Jul 17, 2025 | Exhibit Fbd T 4 | - |
Jul 17, 2025 | Exhibit Fbd T 39 | - |
Jul 17, 2025 | Exhibit Fbd T 38 | - |
Jul 17, 2025 | Exhibit Fbd T 37 | - |
Jul 17, 2025 | Exhibit Fbd T 36 | - |
Jul 17, 2025 | Exhibit Fbd T 35 | - |
Jul 17, 2025 | Exhibit Fbd T 34 | - |
Jul 17, 2025 | Exhibit Fbd T 33 | - |
Jul 17, 2025 | Exhibit Fbd T 32 | - |
Jul 17, 2025 | Exhibit Fbd T 31 | - |
Jul 17, 2025 | Exhibit Fbd T 30 | - |
Jul 17, 2025 | Exhibit Fbd T 3 | - |
Jul 17, 2025 | Exhibit Fbd T 29 | - |
Jul 17, 2025 | Exhibit Fbd T 28 | - |
Jul 17, 2025 | Exhibit Fbd T 27 | - |
Jul 17, 2025 | Exhibit Fbd T 26 | - |
Jul 17, 2025 | Exhibit Fbd T 25 | - |
Jul 17, 2025 | Exhibit Fbd T 24 | - |
Jul 17, 2025 | Exhibit Fbd T 23 | - |
Jul 17, 2025 | Exhibit Fbd T 22 | - |
Jul 17, 2025 | Exhibit Fbd T 21 | - |
Jul 17, 2025 | Exhibit Fbd T 20 | - |
Jul 17, 2025 | Exhibit Fbd T 2 | - |
Jul 17, 2025 | Exhibit Fbd T 19 | - |
Jul 17, 2025 | Exhibit Fbd T 18 | - |
Jul 17, 2025 | Exhibit Fbd T 17 | - |
Jul 17, 2025 | Exhibit Fbd T 16 | - |
Jul 17, 2025 | Exhibit Fbd T 15 | - |
Jul 17, 2025 | Exhibit Fbd T 14 | - |
Jul 17, 2025 | Exhibit Fbd T 13 | - |
Jul 17, 2025 | Exhibit Fbd T 12 | - |
Jul 17, 2025 | Exhibit Fbd T 11 | - |
Jul 17, 2025 | Exhibit Fbd T 10 | - |
Jul 17, 2025 | Exhibit Fbd T 1 | - |
Jul 17, 2025 | Epo Request For Case Pending | - |
Jul 17, 2025 | Acknowledgement Of Lodging | - |
Jul 17, 2025 | 25 07 17 Moderna Vs Genevant Arbutus EP767 Formal Response To Request For Amendments Cc 318331 2025 | - |
Jul 17, 2025 | 07 08 Upc2 EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
Jul 10, 2025 | Formal Checks Request For Correction | - |
Jul 8, 2025 | Exhibit Fbd T 9 | - |
Jul 8, 2025 | Exhibit Fbd T 8 | - |
Jul 8, 2025 | Exhibit Fbd T 70 | - |
Jul 8, 2025 | Exhibit Fbd T 7 | - |
Jul 8, 2025 | Exhibit Fbd T 69 | - |
Jul 8, 2025 | Exhibit Fbd T 68 | - |
Jul 8, 2025 | Exhibit Fbd T 67 | - |
Jul 8, 2025 | Exhibit Fbd T 66 | - |
Jul 8, 2025 | Exhibit Fbd T 65 | - |
Jul 8, 2025 | Exhibit Fbd T 64 | - |
Jul 8, 2025 | Exhibit Fbd T 63 | - |
Jul 8, 2025 | Exhibit Fbd T 62 | - |
Jul 8, 2025 | Exhibit Fbd T 61 | - |
Jul 8, 2025 | Exhibit Fbd T 60 | - |
Jul 8, 2025 | Exhibit Fbd T 6 | - |
Jul 8, 2025 | Exhibit Fbd T 59 | - |
Jul 8, 2025 | Exhibit Fbd T 58 | - |
Jul 8, 2025 | Exhibit Fbd T 57 | - |
Jul 8, 2025 | Exhibit Fbd T 56 | - |
Jul 8, 2025 | Exhibit Fbd T 55 | - |
Jul 8, 2025 | Exhibit Fbd T 54 | - |
Jul 8, 2025 | Exhibit Fbd T 53 | - |
Jul 8, 2025 | Exhibit Fbd T 52 | - |
Jul 8, 2025 | Exhibit Fbd T 51 | - |
Jul 8, 2025 | Exhibit Fbd T 50 | - |
Jul 8, 2025 | Exhibit Fbd T 5 | - |
Jul 8, 2025 | Exhibit Fbd T 49 | - |
Jul 8, 2025 | Exhibit Fbd T 48 | - |
Jul 8, 2025 | Exhibit Fbd T 47 | - |
Jul 8, 2025 | Exhibit Fbd T 46 | - |
Jul 8, 2025 | Exhibit Fbd T 45 | - |
Jul 8, 2025 | Exhibit Fbd T 44 | - |
Jul 8, 2025 | Exhibit Fbd T 43 | - |
Jul 8, 2025 | Exhibit Fbd T 42 | - |
Jul 8, 2025 | Exhibit Fbd T 41 | - |
Jul 8, 2025 | Exhibit Fbd T 40 | - |
Jul 8, 2025 | Exhibit Fbd T 4 | - |
Jul 8, 2025 | Exhibit Fbd T 39 | - |
Jul 8, 2025 | Exhibit Fbd T 38 | - |
Jul 8, 2025 | Exhibit Fbd T 37 | - |
Jul 8, 2025 | Exhibit Fbd T 36 | - |
Jul 8, 2025 | Exhibit Fbd T 35 | - |
Jul 8, 2025 | Exhibit Fbd T 34 | - |
Jul 8, 2025 | Exhibit Fbd T 33 | - |
Jul 8, 2025 | Exhibit Fbd T 32 | - |
Jul 8, 2025 | Exhibit Fbd T 31 | - |
Jul 8, 2025 | Exhibit Fbd T 30 | - |
Jul 8, 2025 | Exhibit Fbd T 3 | - |
Jul 8, 2025 | Exhibit Fbd T 29 | - |
Jul 8, 2025 | Exhibit Fbd T 28 | - |
Jul 8, 2025 | Exhibit Fbd T 27 | - |
Jul 8, 2025 | Exhibit Fbd T 26 | - |
Jul 8, 2025 | Exhibit Fbd T 25 | - |
Jul 8, 2025 | Exhibit Fbd T 24 | - |
Jul 8, 2025 | Exhibit Fbd T 23 | - |
Jul 8, 2025 | Exhibit Fbd T 22 | - |
Jul 8, 2025 | Exhibit Fbd T 21 | - |
Jul 8, 2025 | Exhibit Fbd T 20 | - |
Jul 8, 2025 | Exhibit Fbd T 2 | - |
Jul 8, 2025 | Exhibit Fbd T 19 | - |
Jul 8, 2025 | Exhibit Fbd T 18 | - |
Jul 8, 2025 | Exhibit Fbd T 17 | - |
Jul 8, 2025 | Exhibit Fbd T 16 | - |
Jul 8, 2025 | Exhibit Fbd T 15 | - |
Jul 8, 2025 | Exhibit Fbd T 14 | - |
Jul 8, 2025 | Exhibit Fbd T 13 | - |
Jul 8, 2025 | Exhibit Fbd T 12 | - |
Jul 8, 2025 | Exhibit Fbd T 11 | - |
Jul 8, 2025 | Exhibit Fbd T 10 | - |
Jul 8, 2025 | Exhibit Fbd T 1 | - |
Jul 8, 2025 | EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
Sep 17, 2025 | Panel Appointment | - |
Sep 11, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 11, 2025 | Acknowledgement Of Lodging | - |
Sep 10, 2025 | Reply To Sod + Defence To Cc + App To Amend | - |
Sep 10, 2025 | Formal Checks Notification Of Positive Outcome | - |
Sep 10, 2025 | Exhibit A118 Moderna It Webpage | - |
Sep 10, 2025 | Exhibit A118 Moderna Italy Webpage | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain, Moderna Switzerland And Moderna Netherlan | - |
Sep 10, 2025 | Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla | - |
Sep 10, 2025 | Exhibit A116 Moderna Es Supply Invoicing Eu States | - |
Sep 10, 2025 | Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version) | - |
Sep 10, 2025 | Exhibit A115 Arbutus Genevant Cla Sec | - |
Sep 10, 2025 | Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O | - |
Sep 10, 2025 | Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery | - |
Sep 10, 2025 | Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis | - |
Sep 10, 2025 | Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid | - |
Sep 10, 2025 | Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information | - |
Sep 10, 2025 | Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery | - |
Sep 10, 2025 | Exhibit A108 US61/231,579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A108 US61 231.579 Fbd T 62 P2 | - |
Sep 10, 2025 | Exhibit A107 US61/159,788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A107 US61 159.788 Fbd T 62 P1 | - |
Sep 10, 2025 | Exhibit A106 US61/222,464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A106 US61 222.464 Fbd T 67 P1 | - |
Sep 10, 2025 | Exhibit A105 US61/222/469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A105 US61 222.469 Fbd T 65 P1 | - |
Sep 10, 2025 | Exhibit A104 US61/258,848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A104 US61 258.848 Fbd T 63 P5 | - |
Sep 10, 2025 | Exhibit A103 US61/251,999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A103 US61 251.999 Fbd T 63 P4 | - |
Sep 10, 2025 | Exhibit A102 US61/242,761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A102 US61 242.761 Fbd T 63 P3 | - |
Sep 10, 2025 | Exhibit A101 US61/234,045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A101 US61 234.045 Fbd T 63 P2 | - |
Sep 10, 2025 | Exhibit A100 US61/175,777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A100 US61 175.777 Fbd T 63 P1 | - |
Sep 10, 2025 | Exhibit A099 Register Extract Of Fbd T 66 | - |
Sep 10, 2025 | Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes) | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery: Improved Endosomal Escape And Sustained Pharm | - |
Sep 10, 2025 | Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar | - |
Sep 10, 2025 | Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration | - |
Sep 10, 2025 | Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A094 Jeffs A Scalable Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna | - |
Sep 10, 2025 | Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids | - |
Sep 10, 2025 | Exhibit A092 EP767Claim Requests (Tracked Changes Version) | - |
Sep 10, 2025 | Exhibit A091 EP767Claim Requests (Clean Version) | - |
Sep 10, 2025 | Acknowledgement Of Lodging | - |
Jul 29, 2025 | Notification Of Service | - |
Jul 29, 2025 | Acknowledgement Of Access To Case | - |
Jul 25, 2025 | Epo Communication Check Outcome | - |
Jul 23, 2025 | Epo Communication Check Outcome | - |
Jul 22, 2025 | Document From Epo | - |
Jul 21, 2025 | Document From Epo | - |
Jul 17, 2025 | Panel Appointment | - |
Jul 17, 2025 | Formal Checks Notification Of Positive Outcome | - |
Jul 17, 2025 | Exhibit Fbd T 9 | - |
Jul 17, 2025 | Exhibit Fbd T 8 | - |
Jul 17, 2025 | Exhibit Fbd T 70 | - |
Jul 17, 2025 | Exhibit Fbd T 7 | - |
Jul 17, 2025 | Exhibit Fbd T 69 | - |
Jul 17, 2025 | Exhibit Fbd T 68 | - |
Jul 17, 2025 | Exhibit Fbd T 67 | - |
Jul 17, 2025 | Exhibit Fbd T 66 | - |
Jul 17, 2025 | Exhibit Fbd T 65 | - |
Jul 17, 2025 | Exhibit Fbd T 64 | - |
Jul 17, 2025 | Exhibit Fbd T 63 | - |
Jul 17, 2025 | Exhibit Fbd T 62 | - |
Jul 17, 2025 | Exhibit Fbd T 61 | - |
Jul 17, 2025 | Exhibit Fbd T 60 | - |
Jul 17, 2025 | Exhibit Fbd T 6 | - |
Jul 17, 2025 | Exhibit Fbd T 59 | - |
Jul 17, 2025 | Exhibit Fbd T 58 | - |
Jul 17, 2025 | Exhibit Fbd T 57 | - |
Jul 17, 2025 | Exhibit Fbd T 56 | - |
Jul 17, 2025 | Exhibit Fbd T 55 | - |
Jul 17, 2025 | Exhibit Fbd T 54 | - |
Jul 17, 2025 | Exhibit Fbd T 53 | - |
Jul 17, 2025 | Exhibit Fbd T 52 | - |
Jul 17, 2025 | Exhibit Fbd T 51 | - |
Jul 17, 2025 | Exhibit Fbd T 50 | - |
Jul 17, 2025 | Exhibit Fbd T 5 | - |
Jul 17, 2025 | Exhibit Fbd T 49 | - |
Jul 17, 2025 | Exhibit Fbd T 48 | - |
Jul 17, 2025 | Exhibit Fbd T 47 | - |
Jul 17, 2025 | Exhibit Fbd T 46 | - |
Jul 17, 2025 | Exhibit Fbd T 45 | - |
Jul 17, 2025 | Exhibit Fbd T 44 | - |
Jul 17, 2025 | Exhibit Fbd T 43 | - |
Jul 17, 2025 | Exhibit Fbd T 42 | - |
Jul 17, 2025 | Exhibit Fbd T 41 | - |
Jul 17, 2025 | Exhibit Fbd T 40 | - |
Jul 17, 2025 | Exhibit Fbd T 4 | - |
Jul 17, 2025 | Exhibit Fbd T 39 | - |
Jul 17, 2025 | Exhibit Fbd T 38 | - |
Jul 17, 2025 | Exhibit Fbd T 37 | - |
Jul 17, 2025 | Exhibit Fbd T 36 | - |
Jul 17, 2025 | Exhibit Fbd T 35 | - |
Jul 17, 2025 | Exhibit Fbd T 34 | - |
Jul 17, 2025 | Exhibit Fbd T 33 | - |
Jul 17, 2025 | Exhibit Fbd T 32 | - |
Jul 17, 2025 | Exhibit Fbd T 31 | - |
Jul 17, 2025 | Exhibit Fbd T 30 | - |
Jul 17, 2025 | Exhibit Fbd T 3 | - |
Jul 17, 2025 | Exhibit Fbd T 29 | - |
Jul 17, 2025 | Exhibit Fbd T 28 | - |
Jul 17, 2025 | Exhibit Fbd T 27 | - |
Jul 17, 2025 | Exhibit Fbd T 26 | - |
Jul 17, 2025 | Exhibit Fbd T 25 | - |
Jul 17, 2025 | Exhibit Fbd T 24 | - |
Jul 17, 2025 | Exhibit Fbd T 23 | - |
Jul 17, 2025 | Exhibit Fbd T 22 | - |
Jul 17, 2025 | Exhibit Fbd T 21 | - |
Jul 17, 2025 | Exhibit Fbd T 20 | - |
Jul 17, 2025 | Exhibit Fbd T 2 | - |
Jul 17, 2025 | Exhibit Fbd T 19 | - |
Jul 17, 2025 | Exhibit Fbd T 18 | - |
Jul 17, 2025 | Exhibit Fbd T 17 | - |
Jul 17, 2025 | Exhibit Fbd T 16 | - |
Jul 17, 2025 | Exhibit Fbd T 15 | - |
Jul 17, 2025 | Exhibit Fbd T 14 | - |
Jul 17, 2025 | Exhibit Fbd T 13 | - |
Jul 17, 2025 | Exhibit Fbd T 12 | - |
Jul 17, 2025 | Exhibit Fbd T 11 | - |
Jul 17, 2025 | Exhibit Fbd T 10 | - |
Jul 17, 2025 | Exhibit Fbd T 1 | - |
Jul 17, 2025 | Epo Request For Case Pending | - |
Jul 17, 2025 | Acknowledgement Of Lodging | - |
Jul 17, 2025 | 25 07 17 Moderna Vs Genevant Arbutus EP767 Formal Response To Request For Amendments Cc 318331 2025 | - |
Jul 17, 2025 | 07 08 Upc2 EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
Jul 10, 2025 | Formal Checks Request For Correction | - |
Jul 8, 2025 | Exhibit Fbd T 9 | - |
Jul 8, 2025 | Exhibit Fbd T 8 | - |
Jul 8, 2025 | Exhibit Fbd T 70 | - |
Jul 8, 2025 | Exhibit Fbd T 7 | - |
Jul 8, 2025 | Exhibit Fbd T 69 | - |
Jul 8, 2025 | Exhibit Fbd T 68 | - |
Jul 8, 2025 | Exhibit Fbd T 67 | - |
Jul 8, 2025 | Exhibit Fbd T 66 | - |
Jul 8, 2025 | Exhibit Fbd T 65 | - |
Jul 8, 2025 | Exhibit Fbd T 64 | - |
Jul 8, 2025 | Exhibit Fbd T 63 | - |
Jul 8, 2025 | Exhibit Fbd T 62 | - |
Jul 8, 2025 | Exhibit Fbd T 61 | - |
Jul 8, 2025 | Exhibit Fbd T 60 | - |
Jul 8, 2025 | Exhibit Fbd T 6 | - |
Jul 8, 2025 | Exhibit Fbd T 59 | - |
Jul 8, 2025 | Exhibit Fbd T 58 | - |
Jul 8, 2025 | Exhibit Fbd T 57 | - |
Jul 8, 2025 | Exhibit Fbd T 56 | - |
Jul 8, 2025 | Exhibit Fbd T 55 | - |
Jul 8, 2025 | Exhibit Fbd T 54 | - |
Jul 8, 2025 | Exhibit Fbd T 53 | - |
Jul 8, 2025 | Exhibit Fbd T 52 | - |
Jul 8, 2025 | Exhibit Fbd T 51 | - |
Jul 8, 2025 | Exhibit Fbd T 50 | - |
Jul 8, 2025 | Exhibit Fbd T 5 | - |
Jul 8, 2025 | Exhibit Fbd T 49 | - |
Jul 8, 2025 | Exhibit Fbd T 48 | - |
Jul 8, 2025 | Exhibit Fbd T 47 | - |
Jul 8, 2025 | Exhibit Fbd T 46 | - |
Jul 8, 2025 | Exhibit Fbd T 45 | - |
Jul 8, 2025 | Exhibit Fbd T 44 | - |
Jul 8, 2025 | Exhibit Fbd T 43 | - |
Jul 8, 2025 | Exhibit Fbd T 42 | - |
Jul 8, 2025 | Exhibit Fbd T 41 | - |
Jul 8, 2025 | Exhibit Fbd T 40 | - |
Jul 8, 2025 | Exhibit Fbd T 4 | - |
Jul 8, 2025 | Exhibit Fbd T 39 | - |
Jul 8, 2025 | Exhibit Fbd T 38 | - |
Jul 8, 2025 | Exhibit Fbd T 37 | - |
Jul 8, 2025 | Exhibit Fbd T 36 | - |
Jul 8, 2025 | Exhibit Fbd T 35 | - |
Jul 8, 2025 | Exhibit Fbd T 34 | - |
Jul 8, 2025 | Exhibit Fbd T 33 | - |
Jul 8, 2025 | Exhibit Fbd T 32 | - |
Jul 8, 2025 | Exhibit Fbd T 31 | - |
Jul 8, 2025 | Exhibit Fbd T 30 | - |
Jul 8, 2025 | Exhibit Fbd T 3 | - |
Jul 8, 2025 | Exhibit Fbd T 29 | - |
Jul 8, 2025 | Exhibit Fbd T 28 | - |
Jul 8, 2025 | Exhibit Fbd T 27 | - |
Jul 8, 2025 | Exhibit Fbd T 26 | - |
Jul 8, 2025 | Exhibit Fbd T 25 | - |
Jul 8, 2025 | Exhibit Fbd T 24 | - |
Jul 8, 2025 | Exhibit Fbd T 23 | - |
Jul 8, 2025 | Exhibit Fbd T 22 | - |
Jul 8, 2025 | Exhibit Fbd T 21 | - |
Jul 8, 2025 | Exhibit Fbd T 20 | - |
Jul 8, 2025 | Exhibit Fbd T 2 | - |
Jul 8, 2025 | Exhibit Fbd T 19 | - |
Jul 8, 2025 | Exhibit Fbd T 18 | - |
Jul 8, 2025 | Exhibit Fbd T 17 | - |
Jul 8, 2025 | Exhibit Fbd T 16 | - |
Jul 8, 2025 | Exhibit Fbd T 15 | - |
Jul 8, 2025 | Exhibit Fbd T 14 | - |
Jul 8, 2025 | Exhibit Fbd T 13 | - |
Jul 8, 2025 | Exhibit Fbd T 12 | - |
Jul 8, 2025 | Exhibit Fbd T 11 | - |
Jul 8, 2025 | Exhibit Fbd T 10 | - |
Jul 8, 2025 | Exhibit Fbd T 1 | - |
Jul 8, 2025 | EP767 Moderna Statement Of Defence And Counterclaim For Revocation | - |
This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.
Case Number | Filing Date | Plaintiffs | Defendants |
---|---|---|---|
CC_31831/2025 | Jul 8, 2025 | Moderna | Arbutus Biopharma |
ACT_10284/2025 | Mar 3, 2025 | Arbutus Biopharma, Genevant Sciences | Moderna |
UPC_CFI_192/2025 | Mar 3, 2025 | Arbutus Biopharma, Genevant Sciences | Moderna |
This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.
Case Number | Filing Date | Plaintiffs | Defendants |
---|---|---|---|
App_33094/2025 | Jul 17, 2025 | Moderna | - |
App_32591/2025 | Jul 9, 2025 | Moderna | - |
App_32592/2025 | Jul 9, 2025 | Moderna | - |
This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.
Case Number | Filing Date | Plaintiffs | Defendants |
---|---|---|---|
ORD_34390/2025 | Aug 6, 2025 | Arbutus Biopharma | Moderna |
ORD_34391/2025 | Aug 6, 2025 | Arbutus Biopharma | Moderna |
App_34202/2025 | Aug 1, 2025 | Arbutus Biopharma | - |